<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Banko AV</submitter><funding>Ministry of Education, Science and Technological Development, Republic of Serbia</funding><pagination>e0153498</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4829223</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(4)</volume><pubmed_abstract>Epstein-Barr virus (EBV) infection is a significant factor in the pathogenesis of nasopharyngeal carcinoma, especially in the undifferentiated carcinoma of nasopharyngeal type (UCNT, World Health Organization type III), which is the dominant histopathological type in high-risk areas. The major EBV oncogene is latent membrane protein 1 (LMP1). LMP1 gene shows variability with different tumorigenic and immunogenic potentials. EBV nuclear antigen 1 (EBNA1) regulates progression of EBV-related tumors; however, the influence of EBNA1 sequence variability on tumor pathogenesis is controversial. The aims of this study were to characterize polymorphisms of EBV genes in non-endemic nasopharyngeal carcinoma biopsies and to investigate potential sequence patterns that correlate with the clinical pres</pubmed_abstract><journal>PloS one</journal><pubmed_title>Characterization of the Variability of Epstein-Barr Virus Genes in Nasopharyngeal Biopsies: Potential Predictors for Carcinoma Progression.</pubmed_title><pmcid>PMC4829223</pmcid><funding_grant_id>175073</funding_grant_id><pubmed_authors>Karalic DZ</pubmed_authors><pubmed_authors>Cupic MD</pubmed_authors><pubmed_authors>Folic MM</pubmed_authors><pubmed_authors>Banko AV</pubmed_authors><pubmed_authors>Lazarevic IB</pubmed_authors><pubmed_authors>Djukic VB</pubmed_authors><pubmed_authors>Cirkovic AM</pubmed_authors><pubmed_authors>Jovanovic TP</pubmed_authors></additional><is_claimable>false</is_claimable><name>Characterization of the Variability of Epstein-Barr Virus Genes in Nasopharyngeal Biopsies: Potential Predictors for Carcinoma Progression.</name><description>Epstein-Barr virus (EBV) infection is a significant factor in the pathogenesis of nasopharyngeal carcinoma, especially in the undifferentiated carcinoma of nasopharyngeal type (UCNT, World Health Organization type III), which is the dominant histopathological type in high-risk areas. The major EBV oncogene is latent membrane protein 1 (LMP1). LMP1 gene shows variability with different tumorigenic and immunogenic potentials. EBV nuclear antigen 1 (EBNA1) regulates progression of EBV-related tumors; however, the influence of EBNA1 sequence variability on tumor pathogenesis is controversial. The aims of this study were to characterize polymorphisms of EBV genes in non-endemic nasopharyngeal carcinoma biopsies and to investigate potential sequence patterns that correlate with the clinical pres</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016</publication><modification>2025-05-29T22:25:36.748Z</modification><creation>2019-03-26T22:57:45Z</creation></dates><accession>S-EPMC4829223</accession><cross_references><pubmed>27071030</pubmed><doi>10.1371/journal.pone.0153498</doi></cross_references></HashMap>